Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
a Shot in the Arm Against Breast Cancer
July 9th, 2008
A breast cancer vaccine currently being tested in a Phase II trial has demonstrated to be safe and well tolerated in patients according to a paper to be published in the Journal of Clinical Oncology. The therapeutic breast cancer vaccine AE37 uses a peptide antigen (immune-stimulating fragment) of a cancer gene known as HER-2/neu. This gene/protein is present in many types of cells, but it is over-expressed in a high proportion of breast cancers as well as many others. The vaccine is being developed by Antigen Express, Inc., a wholly owned subsidiary of Generex. Dr. George Peoples of the Brooke Army Medical Center, who presented...
Source: Vaccine Weekly (2008-07-09)
|
